Facebook Linkedin Twitter
Inside Precision Medicine Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma Patients

Multiple myeloma

Microscopic view of bone marrow slide showing Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
News & Features

Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma Patients

0
Human bone marrow under the microscope to illustrate myelofibrosis blood cancer, the diagnosis of which could be aided by new AI tools
News & Features

High-Fiber Diets May Reduce Risk of GVHD after Bone Marrow, Stem Cell Transplants

0
Lymphocytes and biomedical concept, 3d rendering.
News & Features

First Patient Dosed with In Vivo Gene Therapy for CAR T

Jonathan D. Grinstein, PhD
0
Blood Testing
News & Features

Minimal Disease, Maximum Benefit

Chris Anderson
0
Hodgkin lymphoma, light micrograph
News & Features

CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma 

0
Middle aged man with type 2 diabetes using blood sugar measurement device to monitor type 2 diabetes, which is often treated with SGLT2 inhibitors
News & Features

GLP-1 Receptor Agonists May Have Cancer Prevention Benefits in Type 2 Diabetes

0
Microscopic view of bone marrow slide showing Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
Molecular Dx

Mission Bio Launches First-Ever Single-Cell Multiomics Test for Myeloma Research

0
PD-1 Antibody Targeting Immune Checkpoint Inhibitor
News & Features

Pfizer Unveils Priorities for Its New Oncology Organization

0
cancer
News & Features

How Obesity and Physical Activity Affect Multiple Myeloma Risk

0
Micrograph of multiple myeloma neoplasm from bone marrow biopsy
News & Features

Researchers Unveil Individual Risk Prediction Model for Multiple Myeloma

0
123...5Page 1 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine